Health care industry

March 12, 2019 - 5:58 am
MINNETONKA, Minn. (AP) — The nation's largest health insurer is expanding a program that passes rebates from drugmakers directly to the people that use their medications. Beginning next year, all employer-sponsored health care plans that use UnitedHealthcare must give point-of-sale discounts...
Read More
Pedestrians walk to their destination amid the country’s worst-ever power outage, in Caracas, Venezuela, Friday, March 8, 2019. President Nicolas Maduro ordered schools and all government entities closed and told businesses not to open to facilitate work crews trying to restore power. (AP Photo/Fernando Llano)
March 08, 2019 - 7:45 pm
CARACAS, Venezuela (AP) — Venezuela's worst power and communications outage on Friday deepened a sense of isolation and decay, endangering hospital patients, forcing schools and businesses to close and cutting people off from their families, friends and the outside world. While electricity returned...
Read More
FILE- This April 26, 2017, file photo shows the Eli Lilly and Co. corporate headquarters in Indianapolis. Eli Lilly is offering a half-price version of its top-selling insulin Humalog as drugmakers face growing pressure to control prices. The drugmaker says it will introduce a version of the diabetes treatment called Insulin Lispro with a list price 50 percent lower than its current rate, about $275 per vial. (AP Photo/Darron Cummings, File)
March 04, 2019 - 1:32 pm
INDIANAPOLIS (AP) — Eli Lilly is offering a half-price version of a top-selling insulin to ease the financial strain imposed on some patients, but an advocacy group says much bigger changes are needed. The drugmaker said Monday it will introduce a version of the diabetes treatment Humalog that will...
Read More
FILE - In this Oct. 9, 2018, file photo, Zhou Xiaoqin installs a fine glass pipette into a sperm injection microscope in preparation for injecting embryos with Cas9 protein and PCSK9 sgRNA at a lab in Shenzhen in southern China's Guandong province. China has unveiled draft regulations on gene-editing and other new biomedical technologies it considers to be "high-risk." The measures follow claims in November 2018 by Chinese scientist He Jiankui that he helped make the world's first genetically-edited babies. That roiled the global science community and elicited widespread outcry over the procedure's ethical implications. (AP Photo/Mark Schiefelbein, File)
February 27, 2019 - 2:29 am
BEIJING (AP) — China has unveiled draft regulations on gene editing and other potentially risky biomedical technologies after a Chinese scientist's claim of helping to create gene-edited babies roiled the global science community. Under the proposed measures released Tuesday, technology involving...
Read More
From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., Albert Bourla, DVM, Ph.D. Chief Executive Office Pfizer, Olivier Brandicourt, M.D. Chief Executive Officer Sanofi, prepare to testify before the Senate Finance Committee hearing on drug prices, Tuesday, Feb. 26, 2019 on Capitol Hill in Washington. (AP Photo/Pablo Martinez Monsivais)
February 26, 2019 - 12:42 pm
WASHINGTON (AP) — Drawing from their personal experiences, senators on Tuesday chastised drug company executives over the high cost of prescription drugs, as the company officials cautioned that heavy-handed congressional action could jeopardize medical breakthroughs going forward. Tuesday's Senate...
Read More
From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., Albert Bourla, DVM, Ph.D. Chief Executive Office Pfizer, Olivier Brandicourt, M.D. Chief Executive Officer Sanofi, wait to testify before the Senate Finance Committee hearing on drug prices, Tuesday, Feb. 26, 2019 on Capitol Hill in Washington. (AP Photo/Pablo Martinez Monsivais)
February 26, 2019 - 11:41 am
WASHINGTON (AP) — The Latest on top pharmaceutical executives testifying before Senate lawmakers on rising drug prices (all times local): 12:40 p.m. Seven top pharmaceutical executives are telling lawmakers they do not withhold their drugs from potential competitors to stop them from developing...
Read More
February 25, 2019 - 7:29 am
BOSTON (AP) — General Electric is selling its biopharma business to Danaher Corp. for $21.4 billion as it continues to sell off chunks of a once sprawling conglomerate. The biopharma unit, part of GE Life Sciences, generated revenue of about $3 billion last year. Danaher said after tax benefits,...
Read More
February 24, 2019 - 3:43 pm
WASHINGTON (AP) — With health care a top issue for American voters, Congress may actually be moving toward doing something this year to address the high cost of prescription drugs. President Donald Trump, Democrats trying to retire him in 2020, and congressional incumbents of both parties all say...
Read More
FILE - In this Jan. 30, 2017, file photo, attorney Gadeir Abbas speaks during a news conference at the Council on American-Islamic Relations (CAIR) in Washington. The federal government has acknowledged that it shares its terrorist watchlist with more than 1,400 private entities, including hospitals and universities, prompting concerns from civil libertarians that those mistakenly placed on the list could face a wide variety of hassles in their daily lives. (AP Photo/Alex Brandon, File)
February 20, 2019 - 5:21 pm
FALLS CHURCH, Va. (AP) — A Muslim civil rights group called for a congressional investigation Wednesday after its lawsuit revealed that the U.S. government has shared its terrorist watchlist with more than 1,400 private entities, including hospitals and universities. The Council on American-Islamic...
Read More
FILE- In this Aug. 7, 2018, file photo a CVS Pharmacy building sign rests on a Jackson, Miss., store. CVS Health topped fourth-quarter earnings forecasts, but the nation’s second-largest drugstore chain also debuted a 2019 outlook that fell far short of Wall Street expectations. The company said Wednesday, Feb. 20, 2019, that it expects adjusted earnings to range between $6.68 and $6.88 this year. FactSet says analysts expect earnings of $7.35 per share. (AP Photo/Rogelio V. Solis, File)
February 20, 2019 - 11:45 am
CVS Health is setting 2019 earnings expectations well below Wall Street forecasts, as the company struggles to fix part of its business while blending in a major acquisition and attempting to change how customers use its stores. The drugstore chain and pharmacy benefit manager also is dealing with...
Read More

Pages